Exact Mass: 382.1812
Exact Mass Matches: 382.1812
Found 332 metabolites which its exact mass value is equals to given mass value 382.1812
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Hydroxysenkirkine
(3R)-3-hydroxy-16-methoxy-1,2-didehydro-2,3-dihydrotabersonine
Tofisopam
Tofisopam (marketed under brand names Emandaxin and Grandaxin) is a 2,3-benzodiazepine drug which is a benzodiazepine derivative. In contrast to classical 1,4-benzodiazepines, the compound does not bind to the benzodiazepine binding site of the gamma-aminobutyric acid receptor and its psychopharmacological profile differs from such compounds. Although Tofisopam is not approved for sale in North America, it is approved for use in various countries worldwide, including parts of Europe. The D-enantiomer (dextofisopam) is currently in phase II trials in the U.S. for the treatment of irritable bowel syndrome. D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents N - Nervous system > N05 - Psycholeptics > N05B - Anxiolytics > N05BA - Benzodiazepine derivatives C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent
Eletriptan
Eletriptan is only found in individuals that have used or taken this drug. It is a second generation triptan drug developed by Pfizer Inc for the treatment of migraine headaches. [Wikipedia]Eletriptan binds with high affinity to 5-HT1B, 5-HT1D and 5-HT1F receptors, has modest affinity for 5-HT1A, 5-HT1E, 5-HT2B and 5-HT7 receptors, and little or no affinity for 5-HT2A, 5-HT2C, 5-HT3, 5-HT4, 5-HT5A and 5-HT6 receptors. Eletriptan has no significant affinity or pharmacological activity at adrenergic alpha1, alpha2, or beta; dopaminergic D1 or D2; muscarinic; or opioid receptors. Two theories have been proposed to explain the efficacy of 5-HT receptor agonists in migraine. One theory suggests that activation of 5-HT1 receptors located on intracranial blood vessels, including those on the arteriovenous anastomoses, leads to vasoconstriction, which is correlated with the relief of migraine headache. The other hypothesis suggests that activation of 5-HT1 receptors on sensory nerve endings in the trigeminal system results in the inhibition of pro-inflammatory neuropeptide release. N - Nervous system > N02 - Analgesics > N02C - Antimigraine preparations > N02CC - Selective serotonin (5ht1) agonists D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists C78272 - Agent Affecting Nervous System > C47794 - Serotonin Agonist
1,2,10-Trihydroxydihydro-trans-linalyl oxide 7-O-beta-D-glucopyranoside
1,2,10-Trihydroxydihydro-trans-linalyl oxide 7-O-beta-D-glucopyranoside is found in herbs and spices. 1,2,10-Trihydroxydihydro-trans-linalyl oxide 7-O-beta-D-glucopyranoside is a constituent of Foeniculum vulgare (fennel). Constituent of Foeniculum vulgare (fennel). trans-1,2,10-Trihydroxydihydrolinalyl oxide 7-glucoside is found in herbs and spices.
1,4-Bis((o-tolyloxy)acetyl)piperazine
6-Deoxy-4-O-(3,6-di-O-methyl-beta-D-glucopyranosyl)-2,3-di-O-methyl-alpha-L-mannopyranose
1-(2,3-Bis((4-methoxyphenyl)methoxy)propyl)-1H-imidazole
Corynoxeine
1ST159055
Isocorynoxeine is a natural product found in Uncaria tomentosa, Mitragyna parvifolia, and other organisms with data available. See also: Cats Claw (part of). Isocorynoxeine, an isorhynchophylline-related alkaloid, exhibits a dose-dependent inhibition of 5-HT2A receptor-mediated current response with an IC50 of 72.4 μM. Isocorynoxeine, an isorhynchophylline-related alkaloid, exhibits a dose-dependent inhibition of 5-HT2A receptor-mediated current response with an IC50 of 72.4 μM. Isocorynoxeine, an isorhynchophylline-related alkaloid, exhibits a dose-dependent inhibition of 5-HT2A receptor-mediated current response with an IC50 of 72.4 μM.
27KIC0Q2VA
Corynoxeine is a natural product found in Uncaria tomentosa, Mitragyna inermis, and other organisms with data available. See also: Cats Claw (part of). Corynoxeine, isolated from the hook of Uncaria rhynchophylla, is a potent ERK1/ERK2 inhibitor of key PDGF-BB-induced vascular smooth muscle cells (VSMCs) proliferation. Corynoxeine, isolated from the hook of Uncaria rhynchophylla, is a potent ERK1/ERK2 inhibitor of key PDGF-BB-induced vascular smooth muscle cells (VSMCs) proliferation. Corynoxeine, isolated from the hook of Uncaria rhynchophylla, is a potent ERK1/ERK2 inhibitor of key PDGF-BB-induced vascular smooth muscle cells (VSMCs) proliferation.
Gelsempervine A
ADB-FUBINACA
(6aR,9R,9aR)-9-Acetyl-3-[(1E,3E,5S)-3,5-dimethyl-1,3-heptadien-1-yl]-6a-methyl-9,9a-dihydro-6H-furo[2,3-H]isochromene-6,8(6aH)-dione
1-(2,3-dibenzimidazol-2-ylpropyl)-2-methoxybenzene
relative retention time with respect to 9-anthracene Carboxylic Acid is 0.921 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.919 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.915 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.913
methyl (1S,12S,13E)-13-ethylidene-18-(hydroxymethyl)-4-methoxy-8,15-diazapentacyclo[10.5.1.0¹,⁹.0²,⁷.0¹⁰,¹⁵]octadeca-2,4,6,8-tetraene-18-carboxylate
4-(3,4,8,9-Tetrahydro-8-isopropenyl-5-methoxy-6-methyl-2H-furo[2,3-h]-1-benzopyran-3-yl)-3-methoxyphenol
2,6-Dihydroxy-4-[(E)-5-hydroxy-3,7-dimethylocta-2,7-dienyloxy] benzophenone|2,6-dihydroxy-4-[(E)-5-hydroxy-3,7-dimethylocta-2,7-dienyloxy]benzophenone
5-methoxy-2,2-dimethyl-6-(2-methyl-1-oxo-2-butenyl)-10-propyl-2H,8H-benzo[1,2-b,3,4-b]dipyran-8-one|5-Methoxy-2,2-dimethyl-6-(2-methyl-1-oxo-2-butenyl)-10-propyl-2H,8H-benzo[1,2-b:3,4-b]dipyran-8-one|5-Methoxy-2,2-dimethyl-6-<(E)-2-methylbut-2-enoyl>-10-propyl-2H,8H-benzo<1,2-b:3,4-b>dipyran-8-one|GUT-70
(16S,19E)-2,17-epoxy-9,10,12-trimethoxy-(7betaC2)-5beta,16-cyclo-corynoxa-1,19-diene|(19E)-18-demethoxy-gardneramine|18-Desmethoxy-gardneramin|19(E)-18-demethoxygardneramine
kopsifoline A|methyl (1R,4R,5R,13R,20S)-5-hydroxy-8-methoxy-6,16-diazahexacyclo[11.6.1.11.4.05.13.07.12.016.20]henicosa-7(12),8,10,18-tetraene-4-carboxylate
N(1)-Methoxy-19,20-dehydroervatamine|N1-Methoxy-19,20-dehydroervatamine
6-acetyl-3-(3,5-dimethyl-1E,3E-heptadienyl)-9R-hydroxy-8a(R)-methyl-7H-furo[2,3-g]-2-benzopyran-7-one|rotiorinol A
6alpha-phenylacetoxy-4beta,5alpha-epoxygermacra-1(10)E,11-dien-8alpha,12-olide
(21E?)-11xi-Hydroxy-19-methyl-11,24-cyclo-11,12;16,19;23,24-triseco-strychnidin-10,16-dion|(21E?)-11xi-hydroxy-19-methyl-11,24-cyclo-11,12;16,19;23,24-triseco-strychnidine-10,16-dione|Holstiine
3-(2-Hydroxy-7-methyl-3-methylene-6-octenyl)-2,4,6-trihydroxybenzophenone
brasiliamide E|cis-1-acetyl-2-benzyl-5-(3-methoxy-4,5-methylenedioxybenzyl)piperazine
(S)-2,3-dihydro-5,7-dimethoxy-2-(4-methoxyphenyl)-8-(3-methyl-2-butenyl)-4H-1-benzopyran-4-one|mepuberin
19(E)-11-methoxy-9,18-didemethoxygardneramine
A natural product found in Gardneria ovata.
hyperinakin|phenyl(2,4,6-trihydroxy-3-((3-methyl-3-(4-methylpent-3-enyl)oxiran-2-yl)methyl)phenyl)methanone
(3S,16R)-17,21-epoxy-3,17-dihydroxy-1,4-dimethyl-1H-2alpha,4-cyclo-3,4;4,21-diseco-akuammilane-16-carboxylic acid 3-lactone|(6S)-4-(E)-ethylidene-1c-hydroxy-7,16-dimethyl-(4at)-4,4a,5,6-tetrahydro-2H,7H-6ac,11bc-[1]azapropano-6r,11cc-oxaethano-pyrano[4,3-c]carbazol-12-one|Isocorymin|isocorymine
17-methoxy-2-oxo-corynoxa-16,20-diene-16-carboxylic acid methyl ester|Isorhynchophyllin
amyl-1-O-beta-D-apiofuranosyl-1,6-O-beta-D-glucopyranoside
1,2-butanediol 1-O-beta-D-glucopyranoside 6?-O-(2?S,3?R)-2?ethyl-2?,3?-dihydroxybutyrate|microtropin F
(E)-3-(6-hydroxy-3,7-dimethylocta-2,7-dienyl)-2,4,6-trihydroxybenzophenone
10-Hydroxy-11-methoxytabersonine|15-hydroxy-16-methoxy-2,3,6,7-tetradehydro-aspidospermidine-3-carboxylic acid methyl ester|Hydroxy-methoxy-tabersonin|jerantinine A
12-Methoxy-20-oxo-ibogamin-18-carbonsaeure-methylester|12-methoxy-20-oxo-ibogamine-18-carboxylic acid methyl ester
methyl 12-methoxy-N-decarbomethoxychanofruticosinate|methyl 12-methoxy-N1-decarbomethoxychanofruticosinate
(9aR)-9a-Methyl-3-octanoyl-6-trans-propenyl-9aH-furo[3,2-g]isochromen-2,9-dion|(9aR)-9a-methyl-3-octanoyl-6-trans-propenyl-9aH-furo[3,2-g]isochromene-2,9-dione|(R-(E))-9a-methyl-3-(1-oxooctyl)-6-(1-propenyl)-2H-furo[3,2-g][2]benzopyran-2,9(9aH)-dione|Monascorubrin
3beta,4beta,5-trimethoxy-6,6-dimethyl-2H-pyrano-(2,3:7,6)-flavan|3beta-methoxyxuulanin|3??-Methoxyxuulanin
reserpiline
relative retention time with respect to 9-anthracene Carboxylic Acid is 0.759 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.758 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.762
MLS000876965-01!(6aR,9R,9aR)-9-acetyl-3-[(1E,3E,5S)-3,5-dimethylhepta-1,3-dienyl]-6a-methyl-9,9a-dihydrofuro[2,3-h]isochromene-6,8-dione
C22H26N2O4_2H-2,7a-Methanoindolo[2,3-a]quinolizine-13-carboxylic acid, 3-ethylidene-1,3,4,6,7,12b-hexahydro-13-(hydroxymethyl)-9-methoxy-, methyl ester, (2S,3E,7aS)
C23H26O5_6H-Furo[2,3-h]-2-benzopyran-6,8(6aH)-dione, 9-acetyl-3-[(1E,3E,5S)-3,5-dimethyl-1,3-heptadien-1-yl]-9,9a-dihydro-6a-methyl-, (6aR,9R,9aR)
tofisopam
D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents N - Nervous system > N05 - Psycholeptics > N05B - Anxiolytics > N05BA - Benzodiazepine derivatives C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent
Reserpinine
Origin: Plant; SubCategory_DNP: Monoterpenoid indole alkaloids, Yohimbinoid alkaloids, Indole alkaloids
Eletriptan
N - Nervous system > N02 - Analgesics > N02C - Antimigraine preparations > N02CC - Selective serotonin (5ht1) agonists D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists C78272 - Agent Affecting Nervous System > C47794 - Serotonin Agonist
1,2,10-Trihydroxydihydro-trans-linalyl oxide 7-O-b-D-glucopyranoside
methyl (19alpha)-16,17-didehydro-11-methoxy-19-methyloxayohimban-16-carboxylate
[4-[4-(2,2-dimethylpropanoyloxy)benzoyl]phenyl] 2,2-dimethylpropanoate
Calpain Inhibitor III
D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015853 - Cysteine Proteinase Inhibitors
Thiourea, N-[2-(1H-benzimidazol-2-yl)ethyl]-N-(2-methoxyethyl)-N-[(4-methylphenyl)methyl]- (9CI)
Gdc-0084
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2152 - Phosphatidylinositide 3-Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor D004791 - Enzyme Inhibitors
Dextofisopam
D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents C78272 - Agent Affecting Nervous System > C29698 - Antispasmodic Agent
N-Ethyl-4-{[5-(Methoxycarbamoyl)-2-Methylphenyl]amino}-5-Methylpyrrolo[2,1-F][1,2,4]triazine-6-Carboxamide
Levotofisopam
D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent
Jerantinine A
An indole alkaloid that is tabersonine substituted by hydroxy group at position 10 and a methoxy group at position 11. Isolated from Tabernaemontana corymbosa and Hazunta modesta, it exhibits cytotoxicity against human KB cells.
Rotiorinol A
An azaphilone that is 9,9a-dihydro-2H-furo[3,2-g]isochromen-2-one substituted by an acetyl group at position 3, a hydroxy group at position 9, a 3,5-dimethylhepta-1,3-dien-1-yl group at position 6 and a methyl group at position 9a. It has been isolated from Chaetomium cupreum and exhibits antifungal activity.
2-[1-(1H-benzimidazol-2-yl)-3-(2-methoxyphenyl)propan-2-yl]-1H-benzimidazole
2-{5-[Amino(iminio)methyl]-6-fluoro-1H-benzimidazol-2-YL}-6-[(2-methylcyclohexyl)oxy]benzenolate
6-Carbamimidoyl-2-[2-hydroxy-6-(4-hydroxy-phenyl)-indan-1-YL]-hexanoic acid
Methyl 11-methoxy-19-methyl-16,17-didehydro-18-oxayohimban-16-carboxylate
(2S,5S)-6-[(2R,3S,4R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]-2,5-bis(azaniumyl)hexanoate
methyl (1R,13R,20S)-13-ethyl-5-methoxy-10-oxa-8,17-diazahexacyclo[11.6.1.01,9.02,7.09,11.017,20]icosa-2(7),3,5,14-tetraene-11-carboxylate
methyl (Z)-2-(6-ethenyl-2-oxospiro[1H-indole-3,1-3,5,6,7,8,8a-hexahydro-2H-indolizine]-7-yl)-3-methoxyprop-2-enoate
6-Deoxy-4-O-(3,6-di-O-methyl-beta-D-glucopyranosyl)-2,3-di-O-methyl-alpha-L-mannopyranose
2-[3-[(4-methylphenyl)methyl]-7-oxo-6-triazolo[4,5-d]pyrimidinyl]-N-(2-oxolanylmethyl)acetamide
1-[5-[[Anilino(oxo)methyl]amino]-1,3-dimethyl-2-oxo-4-imidazolidinyl]-3-phenylurea
19(E)-18-demethoxygardneramine
A natural product found in Gardneria ovata.
[(1R,5S)-7-[4-[(E)-2-phenylethenyl]phenyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]-pyrazin-2-ylmethanone
cyclobutyl-[(2R,3R)-2-(hydroxymethyl)-3-phenyl-6-(3,3,3-trifluoropropyl)-1,6-diazaspiro[3.3]heptan-1-yl]methanone
cyclobutyl-[(2S,3R)-2-(hydroxymethyl)-3-phenyl-6-(3,3,3-trifluoropropyl)-1,6-diazaspiro[3.3]heptan-1-yl]methanone
(1-Pentanoyloxy-3-phosphonooxypropan-2-yl) octanoate
(1-Hexanoyloxy-3-phosphonooxypropan-2-yl) heptanoate
(1-Butanoyloxy-3-phosphonooxypropan-2-yl) nonanoate
(1-Acetyloxy-3-phosphonooxypropan-2-yl) undecanoate
(1-Phosphonooxy-3-propanoyloxypropan-2-yl) decanoate
2,5,7,8-Tetramethyl-2-[2-[(1H-benzimidazol-2-yl)thio]ethyl]chroman-6-ol
(1R,4Z,6R,7S,17S)-4-ethylidene-7,17-dihydroxy-7-(hydroxymethyl)-6,14-dimethyl-2,9-dioxa-14-azoniatricyclo[9.5.1.014,17]heptadec-11-ene-3,8-dione
(3R)-1,2-didehydro-3-hydroxy-16-methoxy-2,3-dihydrotabersonine
A monoterpenoid indole alkaloid that is a reactive intermediate in the biosynthesis of vindoline by Catharanthus roseus.
1,2,10-Trihydroxydihydro-trans-linalyl oxide 7-O-beta-D-glucopyranoside
beta-D-Glup3,6Me2-(1->4)-alpha-L-Rhap2,3-Me2
A disaccharide derivative consisting of 2,3-di-O-methyl-alpha-L-rhamnose having a 3,6-dimethyl-alpha-D-arabino-hexosyl residue attached at the 4-position.
Roxindole (hydrochloride)
Roxindole hydrochloride (EMD 38362), an indot-alkyl-pipenidine, is a potent agonist at dopamine autoreceptors, with an affinity for the D2-like subtype in the low nanomolar range. Roxindole can be used for the research of positive and negative schizophrenic symptoms. Roxindole is a 5-HT1A agonist and 5-HT uptake inhibitor with high affinity for 5-HT1A (IC50=0.9 nM). Antipsychotic and antidepressant activities[1][2][3].
9a-methyl-3-octanoyl-6-(prop-1-en-1-yl)furo[3,2-g]isochromene-2,9-dione
(6ar)-9-acetyl-3-[(1e,3e,5s)-3,5-dimethylhepta-1,3-dien-1-yl]-6a-methyl-9h,9ah-furo[2,3-h]isochromene-6,8-dione
methyl (1s,15r,16s,20s)-6-methoxy-16-methyl-17-oxa-3,13-diazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8,18-pentaene-19-carboxylate
5-methoxy-2,2-dimethyl-6-(2-methylbut-2-enoyl)-10-propylpyrano[2,3-h]chromen-8-one
methyl (9s,10r,12s,13s,14s,15s)-9-hydroxy-15-methyl-16-oxa-8,18-diazahexacyclo[10.8.1.1¹⁰,¹⁴.0²,⁷.0⁸,²¹.0¹³,¹⁸]docosa-1(21),2,4,6-tetraene-12-carboxylate
methyl 7-methoxy-20-oxo-5,15-diazahexacyclo[11.5.2.1¹,¹².0⁴,¹².0⁶,¹¹.0¹⁵,²¹]henicosa-6,8,10-triene-4-carboxylate
methyl 2-{3-ethenyl-8-hydroxy-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-2-yl}-3-methoxyprop-2-enoate
2-({[3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-6-(3-methylbutoxy)oxane-3,4,5-triol
methyl 20-hydroxy-11,18-dimethyl-17-oxa-1,11-diazapentacyclo[10.8.1.0²,⁷.0⁸,²¹.0¹⁴,¹⁹]henicosa-2,4,6,8(21),15-pentaene-15-carboxylate
methyl (1s,15r,17s,18s)-17-ethyl-7-methoxy-14-oxo-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8-tetraene-1-carboxylate
(2r,3r,4s,5s,6r)-2-[(2r)-pentan-2-yloxy]-6-({[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxane-3,4,5-triol
methyl 2-{6'-ethenyl-2-hydroxy-3',5',6',7',8',8'a-hexahydro-2'h-spiro[indole-3,1'-indolizin]-7'-yl}-3-methoxyprop-2-enoate
methyl (1r,9s,11s,14e,15s,17s,19r)-14-ethylidene-19-(hydroxymethyl)-2-methyl-18-oxa-2,12-diazahexacyclo[9.6.1.1⁹,¹⁵.0¹,⁹.0³,⁸.0¹²,¹⁷]nonadeca-3,5,7-triene-19-carboxylate
(1r,10s,12r,13r,14r,16s,17s,18r)-14-hydroxy-13-[(1r)-1-methoxyethyl]-8,15-diazahexacyclo[14.2.1.0¹,⁹.0²,⁷.0¹⁰,¹⁵.0¹²,¹⁷]nonadeca-2,4,6,8-tetraen-18-yl acetate
methyl (1r,2s,10s,15e,16s,17r,18s)-15-ethylidene-18-hydroxy-3-methyl-19-oxa-3,13-diazahexacyclo[14.3.1.0²,¹⁰.0²,¹³.0⁴,⁹.0¹⁰,¹⁷]icosa-4,6,8-triene-17-carboxylate
methyl 5-methoxy-15-oxa-8,19-diazahexacyclo[10.9.1.0¹,⁹.0²,⁷.0¹²,¹⁶.0¹⁹,²²]docosa-2,4,6,9-tetraene-10-carboxylate
methyl 15-ethylidene-18-(hydroxymethyl)-17-methyl-12-oxo-10,17-diazatetracyclo[12.3.1.0³,¹¹.0⁴,⁹]octadeca-3(11),4,6,8-tetraene-18-carboxylate
methyl 17-ethyl-6-methoxy-14-oxo-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8-tetraene-1-carboxylate
methyl (1s,15r,17s,18s)-17-ethyl-6-methoxy-14-oxo-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8-tetraene-1-carboxylate
methyl (1r,10s,12r,14s,15s)-14-ethyl-4-methoxy-19-oxa-8,16-diazahexacyclo[10.6.2.0¹,⁹.0²,⁷.0¹⁰,¹⁵.0¹⁶,²⁰]icosa-2,4,6,8-tetraene-10-carboxylate
methyl (2e)-2-[(6'r,7's)-6'-ethenyl-2-hydroxy-3',5',6',7',8',8'a-hexahydro-2'h-spiro[indole-3,1'-indolizin]-7'-yl]-3-methoxyprop-2-enoate
2-[3-hydroxy-2-(3-methylbut-2-en-1-yl)benzoyl]-4-(3-methylbut-2-en-1-yl)benzene-1,3,5-triol
methyl (1s,9s,14e,15s,16r,19s)-14-ethylidene-6-hydroxy-2-methyl-18-oxa-2,12-diazahexacyclo[13.3.2.0¹,⁹.0³,⁸.0⁹,¹⁶.0¹²,¹⁹]icosa-3,5,7-triene-16-carboxylate
7-benzoyl-2-(2-hydroxypropan-2-yl)-5-(3-methylbut-2-en-1-yl)-2,3-dihydro-1-benzofuran-4,6-diol
methyl 8-methoxy-16-methyl-17-oxa-3,13-diazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8,18-pentaene-19-carboxylate
14-β-hydroxy-3-isorauniticine
{"Ingredient_id": "HBIN001384","Ingredient_name": "14-\u03b2-hydroxy-3-isorauniticine","Alias": "NA","Ingredient_formula": "C22H26N2O4","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10263","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
2,6-dihydroxy-4-[(e)-5-hydroxy-3,7-dimethyl-octa-2,7-dienyloxy] benzophenone
{"Ingredient_id": "HBIN004880","Ingredient_name": "2,6-dihydroxy-4-[(e)-5-hydroxy-3,7-dimethyl-octa-2,7-dienyloxy] benzophenone","Alias": "NA","Ingredient_formula": "C23H26O5","Ingredient_Smile": "CC(=C)CC(CC(=CCOC1=CC(=C(C(=C1)O)C(=O)C2=CC=CC=C2)O)C)O","Ingredient_weight": "382.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "5907","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "11338042","DrugBank_id": "NA"}
anonocine
{"Ingredient_id": "HBIN016259","Ingredient_name": "anonocine","Alias": "NA","Ingredient_formula": "C19H28NO7+","Ingredient_Smile": "CC1CC(=CCO)C(=O)OC2CC[N+]3(C2(C(=CC3)COC(=O)C1(C)O)O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "36195","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}